Skip to main content.
Menu

Clinton vs. Trump: What's Next for U.S. Health Care

In the 2016 presidential election between Hillary Clinton and Donald Trump, health care has received scant attention. Yet it remains among the most urgent issues facing Americans. Insurance premiums continue their upward march, out-of-pocket costs are soaring, health insurance exchanges keep losing major insurers and every month seems to bring a fresh wave of outrage over skyrocketing prescription drug prices. What policies might address these problems, and how do the candidates’ health platforms differ? While the Democratic candidate has spelled out in great detail her health care platform, the Republican nominee has vowed to repeal Obamacare, yet has provided few policy specifics. This webinar will give an overview of each candidates’ healthcare prescriptions, forecast post-election scenarios and provide reporters with crucial context for covering one of the election’s most important, but overlooked issues.

WHEN: October 28, from 10-11 a.m. PT / 1-2 p.m. ET

Our distinguished panel includes:

Sara Collins, Ph.D., is vice president of the health care coverage and access program at the Commonwealth Fund. An economist, Collins joined Commonwealth in 2002 and has led the organization’s national program on health insurance since 2005. Collins has led several national surveys on health insurance and authored numerous reports, issue briefs and journal articles on health insurance coverage and policy. She has also provided invited testimony before several Congressional committees and subcommittees. Prior to joining Commonwealth, Collins was associate director and senior research associate at the New York Academy of Medicine, Division of Health and Science Policy. Earlier in her career, she was an associate editor at U.S. News & World Report, a senior economist at Health Economics Research, and a senior health policy analyst in the New York City Office of the Public Advocate. She holds an A.B. in economics from Washington University and a Ph.D. in economics from George Washington University.

Diana Furchtgott-Roth is a senior fellow at the Manhattan Institute, director of MI's Economics21 program, and a columnist for MarketWatch.com and Tax Notes. Furchtgott-Roth also currently serves as a volunteer adviser to Donald J. Trump's 2016 presidential campaign. During 2003–05, she was chief economist of the U.S. Department of Labor. In 2001–02, Furchtgott-Roth was chief of staff of President George W. Bush’s Council of Economic Advisers. During 1991–93, she was deputy executive director of the White House Domestic Policy Council and associate director of the Office of Policy Planning under President George H. W. Bush. Furchtgott-Roth was an economist on the staff of President Reagan’s Council of Economic Advisers in 1986–87. As an author, her titles include “Women’s Figures: An Illustrated Guide to the Economic Progress of Women in America” (2012); “Regulating to Disaster: How Green Jobs Policies Are Damaging America’s Economy” (2012); and “How Obama’s Gender Policies Undermine America (2010).” She co-coauthored “Disinherited: How Washington Is Betraying America's Young” (2015) with Jared Meyer.

Jennifer Haberkorn is a senior health care reporter for Politico and Politico Pro. She’s covered the Affordable Care Act since it was being debated in Congress in 2009. Since then, she has written about the law from Capitol Hill, the federal agencies, the courts and outside the Beltway. Before arriving at Politico, Haberkorn covered Congress and local business news for The Washington Times. A former fellow and current senior fellow for the USC Annenberg Health Journalism Fellowships, her work has also appeared in Health Affairs and The New Republic. Haberkorn is a graduate of Marquette University, where she majored in journalism and served as editor of The Marquette Tribune.

Webinars are free and made possible by the .


 

 

 

 

 

Suggested Reading

Journalism:

“,” by Louis Nelson and Eli Stokols, Politico, Oct. 25

“,” by Lanhee Chen, CNN, Oct. 25

“,” The New York Times Editorial Board, Oct. 25

“,” by John Cassidy, The New Yorker, Oct. 25

“,” by Jennifer Haberkorn, Politico, Oct. 20

“,” The New York Times, Sept. 23

“,” by Jennifer Haberkorn, Politico, Sept. 22

“,” by Zachary Tracer and Sahil Kapur, Bloomberg, Sept. 22

“,” by Dr. Dhruv Khullar, ABC News, Sept. 23

“,” by Aaron Caroll, The Incidental Economist, Oct. 25

“,” by Noam Levey and Michael Memoli, Los Angeles Times, Sept. 16

“,” by Eliza Collins, Sept. 16

“,” by Michelle Cortez and Zachary Tracer, Bloomberg, Sept. 15

“,” by Dr. Aaron Carroll, JAMA Forum

“” by Harris Meyer, Modern Healthcare, July 23

"," by Julie Rovner, Kaiser Health News, Oct. 10

“,” by Dylan Scott, STAT, Oct. 11

“,” by Jennifer Haberkorn, Politico, June 22

“,” by Diana Furchtgott-Roth and Grace-Marie Turner, The New York Times, Feb. 13, 2016

“,” by Diana Furchtgott-Roth, MarketWatch, March 25, 2016

“ by Diana Furchtgott-Roth and Jared Meyer, National Review, May 19, 2015 

 

Reports:

“,” by Hillary Clinton, The New England Journal of Medicine

“,” by Kaiser Family Foundation, Sept. 23

“,” by Caroline Rosenzweig, Usha Ranji, and Alina Salganicoff, Kaiser Family Foundation, Oct. 12

“,” by Sara R. Collins and Sophie Beutel, The Commonwealth Fund, Sept. 23

“,” The Commonwealth Fund and RAND Corporation

“,” by Jim Capretta, American Enterprise Institute 

“,” Manhattan Institute, 2013

 

The Health Matters Webinar series is supported by the National Institute for Health Care Management Foundation. The Center for Health Journalism is solely responsible for the selection of webinar topics and speakers.

Announcements

Got a great idea for an ambitious reporting project on a California health issue?  Let us fund it.  Apply now for the 2019 California Fellowship, which provides $1,000 reporting grants and six months of expert mentoring to 20 journalists, community engagement grants of up to $2,000, specialized mentoring, to five.

CONNECT WITH THE COMMUNITY

https://steroid-pharm.com

https://steroid-pharm.com

dopingman.com.ua/tabletirovannyie-steroidyi/metandienon/danabol.html